Evaluation of antibody production and chIL6 levels after broiler vaccination with different Infectious bronchitis vaccine
DOI:
https://doi.org/10.48047/2v13j859Keywords:
IBV, Broiler, Vaccine, Antibody, IL6Abstract
Background: The avian infectious bronchitis virus (IBV) is a widespread virus that specifically targets the
upper respiratory tract, kidneys, and reproductive system, it has a huge economic impact on the poultry business,
costing millions of dollars globally each year; there is a wide variety of IBV vaccines that protect against
different serotypes of the virus but the absence of cross-protection between imported vaccine strains and field
strains may explain the inability to implement an effective vaccination program against IBV.
Downloads
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
